The effect of glucagon on DNA synthesis in rat spleen and bone marrow  by Yeoh, G.C.T. et al.
Volume 22, number I FEBS LETTERS April 1972 
THE EFFECT OF GLUCAGON ON DNA SYNTHESIS IN RAT SPLEEN AND BONE MARROW 
G.C.T. YEOH, R.F. TOIA, J.M. KIDD and I.T. OLIVER 
Department of Biochemistry, University of Western Australia, Nedlands, Western Australia 6009 
Received 14 February 1972 
1. Introduction 
It has been demonstrated that glucagon will enhance 
the rate of radioactive thymidine incorporation into 
DNA in foetal and postnatal rat liver in vitro. The 
effectiveness of the hormone is age dependent, and 
declines postnatally [l] . There is a good correlation 
between the diminishing glucagon effect and the 
reduction in erythropoietic content of foetal rat liver 
[2,3] . During the development of the rat embryo, 
the sites of maximal erythropoietic activity are the 
yolk sac, the liver, the spleen and the bone marrow in 
chronological order [3] . This communication reports 
the results of experiments on the effect of glucagon 
on DNA synthesis in non-hepatic erythropoietic tissue 
in the rat. 
2. Methods 
The preparation of spleen slices, conditions for 
incorporation of 3H-thymidine into DNA, and the 
extraction of DNA for specific radioactivity determina- 
tion is as described for foetal liver studies [l] Spleens 
from 4 littermate (9 day old) animals were pooled for 
each determination in order to have suffifient tissue for 
DNA extraction. In the case of foetal animals where the 
organ was considerably smaller, the experiments were 
carried out on diced spleen instead of slices. A glucagon 
concentration of 75 pg/ml, which was previously shown 
to yield a maximal effect in liver slices, [ 1 ] was used 
for these experiments. 
Bone marrow was obtained from adult male rats by 
flushing the femur and tibia bones with cold Krebs 
ringer phosphate buffer pH 7.4 from a syringe. The 
cells were concentrated by centrifugation at 5” and 
the total yield from each animal made up to 3 ml. The 
tissue was thoroughly dispersed by repeated aspirations 
using a syringe. 1 ml aliquots were taken for incorpor- 
ation studies and 0.5 ml of the remainder was extracted 
with 0.5 N HClO, (final concentration) at 90” for 15 
min. The DNA content of aliquots of the extract was 
determined by the diphenylamine method of Burton 
[4]. For the time course experiment, the total bone 
marrow from 3 animals was pooled. Glucagon (50 
/.&ml final cont.) or saline was introduced at the 
commencement of the 5 min preincubation period. 
The reaction was started by the addition of 3H-thymi- 
dine (2.7 nmoles, 1 PCi). Routine incubations were 
for 10 min at 37” in a shaking water bath (120 
oscillations/min). The reaction was terminated by 
addition of 200 ~1 of 3 N HClO,. The precipitate was 
then washed by resuspension and centrifugation (15 
set at 1000 g) 5 times with 0.5 N HClO, (3 ml). This 
procedure removed allunincorporated counts since 
blanks which received 3 N HCIO, prior to 3H-thymi- 
dine contained no counts above the background level. 
The washed pellet was dissolved in 1 M hyamine 
hydroxide (0.5 ml), mixed with 10 ml of diotol [5] 
and radioactivity determined in a Nuclear Chicago 
Model 6860 liquid scintillation spectrometer. Quench 
corrections were made by the channels ratio method 
and count rates were adjusted to a standard 2 1% 
efficiency. The results are expressed as cpm/mg DNA. 
The specific activity of DNA isolated from bone 
marrow cells exposed to 3H-thymidine under similar 
conditions compared favourably with the specific 
activities obtained using this simpler procedure. 
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Fig. 1. Effect of glucagon on incorporation of 3H-thymidine 
into DNA of bone marrow cells. The conditions of assay are 
as described in the Methods section. (0 -a -a): Represents 
control flasks; (0 - - 0 - - 0): represents glucagon (50 pg/ml) 
treated flasks. 
Table 1 
The effect of glucagon on 3H-thymidine incorporation into 
DNA of 91 day old rat spleen. 
Specific activity of DNA 
(cpm/mg DNA) 
Control 
Mean 
+ SE 
p value: 
7,622 
9,104 
9,820 
8,635 
7,622 
9,094 
8,650 
360 
Glucagon 
9,052 
11,984 
11,033 
10,592 
8,382 
13,804 
10,800 
810 
0.02 > p > 0.01 
Table 2 
The effect of glucagon on 3H-thymidine incorporation into 
DNA of foetal rat spleen. 
Specific activity of DNA 
(cpmlmg DNA) 
~- 
Mean 
?r SE 
p value: 
Control 
47,796 
33,742 
47,249 
5 3,298 
38,952 
44,208 
3,478 
Glucagon 
50,466 
36,850 
so,74 1 
50,358 
38,643 
45,411 
3,143 
0.4 > p > 0.3 
Animals were between 2 1 and 22 days gestational age. 
Glucagon (75 @g/ml was introduced at the commencement 
of the preincubation period (10 min). 3H-thymidine 
(1 &i/2.7 nmoles) was added to start the reaction. A 20 min 
incubation was used routinely. Statistical analysis was by the 
paired difference f test. 
Table 3 
The effect of glucagon on 3H-thymidine incorporation into 
DNA of adult rat bone narrow. 
-___-___ -___ 
Specific activity of DNA 
(cpm/mg DNA) 
~- 
Mean 
f SE 
p value: 
- 
Controls 
9,497 
11,763 
11,911 
9,726 
9,120 
10,790 
10,468 
489 
Glucagon 
12,677 
12,942 
12,053 
10,737 
9,690 
11,710 
11,635 
502 
0.05 > p > 0.02 
Conditions of assay are as described in the methods. Glucagon 
(50 pg/ml) was introduced at the commencement of the 50 
min preincubation period. Statistical analysis was by the 
paired difference i test. 
Glucagon (75 Hg/ml) was introduced at the commencement 
of the preincubation period (10 min). 3H-thymidine (1 )&i/ 
2.7 nmoles) was added to start the reaction. A 20 mm incuba- 
tion was used routinely. Statistical analysis was by the paired 
difference f test. 
102 
Volume 22, number 1 FEBS LETTERS April 1972 
3. Rest&s 
Table 1 shows that glucagon stimulates 3H-thymidine 
incorporation into DNA in spleen preparations from 9 
day old rats in vitro. Statistical analysis (t test) reveals 
that controls and tests are significantly different 
(0.01 <p < 0.02). Table 2 summarizes results from 
foetal spleen where no significant stimulation of DNA 
synthesis was found. Similar data was obtained when 
1 day postnatal spleen was studied. 
Fig. 1 shows a typical time course of 3H-thymidine 
incorporation into DNA of bone marrow cells in the 
absence and presence of glucagon. Characteristically, 
when the incubation period is extended beyond the 
linear region, the specific activity of DNA in glucagon 
treated flasks is less than that of controls. The effect 
of glucagon is marginal (11% increase) for incubations 
within the linear region of the time course. Analysis 
of the results from 6 experiments gives a p value of 
between 0.05 and 0.02 (table 3). 
4. Discussion 
A study of hormonal effects on DNA synthesis in 
neonatal rat liver slices revealed a stimulatory effect of 
glucagon which was age dependent [l] Data suggested 
that in the course of development, the foetal liver lost 
its ability to respond to the hormone. It is well estab- 
lished that foetal liver is a major site of haemopoiesis 
and that its erythropoietic role diminishes with age 
[2,3] . The decline in haemopoietic cell content of 
foetal liver parallels the reduction in effectiveness of 
glucagon which occurs postnatally, and thus the effect 
may be confined to the erythropoietic component of 
neonatal liver. 
Data obtained from studies on other erythropoietic 
tissue, i.e., the spleen and bone marrow, could thus 
provide evidence in support of the proposed cellular 
site of glucagon action. These investigations reveal that 
glucagon significantly elevated DNA synthesis in spleen 
from 91 day old rats. At this age, the tissue exhibits 
maximal erythropoietic activity. Furthermore, foetal 
spleen, which has a higher rate of DNA synthesis, 
though considerably less erythropoietic activity, is not 
affected by glucagon (table 2). 
Due to the scarcity of tissue it was not possible to 
examine the effect of glucagon on bone marrow at the 
time of maximal erythropoiesis (about 10 days 
postnatal). Bone marrow erythropoiesis gradually 
declines in postnatal life in contrast to the liver and 
spleen [3]. Studies using adult rat bone marrow show 
that a significant, though marginal, elevation of 
3H-thymidine incorporation results from treatment 
with glucagon. 
The level of stimulation observed for each of the 
haemopoietic tissues varies (liver, 47%; spleen, 25%; 
bone narrow, 11%). Preliminary autoradiographic data 
indicates that in foetal liver the hormonal effect may 
be restricted to a minor cell population. The varying 
effectiveness of glucagon possibly reflects the relative 
proportion of target cells in each of the tissues. 
Current studies in foetal rat liver have failed to 
demonstrate an effect of the hormone on enzymes 
involved in the incorporation of thymidine into DNA 
[6] . It has been suggested by several investigators 
that endonuclease [5] may play an important role in 
regulation of DNA synthesis [7,8,9] . The enzyme 
can determine the state of the primer [lo] , the 
availability of 3’-OH ends as well as the rate of degrad- 
ation of product. The time course of 3H-thymidine 
incorporation into DNA (fig. 1) repeatedly shows an 
initial stimulation by glucagon but an inhibitory effect 
at extended incubation times. This paradoxical effect 
of the hormone suggests the possibility that it is acting 
by enhancing the activity of an endonuclease. Initially, 
this may promote the activity of the polymerizing 
enzyme by increasing the availability of 3’-OH ends 
and/or by altering the state of the primer DNA (if the 
polymerase prefers denatured primer). Subsequently 
the endonuclease attains a level of activity whereby 
its degradative role predominants, thus accounting for 
the lower specific activity of glucagon treated tissue 
at 20 and 25 min incubation times. 
The results of this study lend support to the pro- 
posal that the cellular site of glucagon action in foetal 
rat liver may be the haemopoietic cells. . 
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